340B Program Puts Manufacturers At Risk of Duplicate Drug Discounts

Samankaltaisia teoksia

• Cost Consequences of the 340B Drug Discount Program
  Tekijä: Conti, Rena M., et al.
  Julkaistu: (2013)
• The unintended consequences of the 340B safety‐net drug discount program
  Tekijä: Thomas, Samuel, et al.
  Julkaistu: (2020)
• The 340B Discount Drug Program At Ozarks Medical Center: An Economic Stimulus Plan for Missouri
  Tekijä: Barlas, Stephen
  Julkaistu: (2011)
• Excluding Orphan Drugs from the 340B Drug Discount Program: the Impact on 18 Critical Access Hospitals
  Tekijä: Madeline Carpinelli Wallack, et al.
  Julkaistu: (2012-01-01)
• The 340B Drug Discount Program: Hospitals Generate Profits By Expanding To Reach More Affluent Communities
  Tekijä: Conti, Rena M., et al.
  Julkaistu: (2014)